Literature DB >> 30216554

Acute Tissue Mineral Deposition in Response to a Phosphate Pulse in Experimental CKD.

Jason Ge Zelt1,2,3, Bruno A Svajger1, Kieran Quinn1,4, Mandy E Turner1, Kimberly J Laverty1, Bonnie Shum1, Rachel M Holden5, Michael A Adams1.   

Abstract

Pathogenic accumulation of calcium (Ca) and phosphate (PO4 ) in vasculature is a sentinel of advancing cardiovascular disease in chronic kidney disease (CKD). This study sought to characterize acute distribution patterns of radiolabeled 33 PO4 and 45 Ca in cardiovascular tissues of rats with CKD (0.25% dietary adenine). The disposition of 33 PO4 and 45 Ca was assessed in blood and 36 tissues after a 10-minute intravenous infusion of one of the following: (i) PO4  pulse + tracer 33 PO4 ; (ii) PO4  pulse + tracer 45 Ca; or (iii) saline + tracer 45 Ca in CKD and non-CKD animals. After the infusion, 33 PO4 in blood was elevated (2.3× at 10 minutes, 3.5× at 30 minutes, p < 0.05) in CKD compared with non-CKD. In contrast, there was no difference in clearance of 45 Ca from the blood. Compared with controls, CKD rats had a markedly increased 33 PO4 incorporation in several tissues (skeletal muscle, 7.8×; heart, 5.5×), but accrual was most pronounced in the vasculature (24.8×). There was a significant, but smaller, increase in 45 Ca accrual in the vasculature of CKD rats (1.25×), particularly in the calcified rat, in response to the acute phosphate load. Based on the pattern of tissue uptake of 33 PO4 and 45 Ca, this study revealed that an increase in circulating PO4 is an important stimulus for the accumulation of these minerals in vascular tissue in CKD. This response is further enhanced when vascular calcification is also present. The finding of enhanced vascular mineral deposition in response to an acute PO4  pulse provides evidence of significant tissue-specific susceptibility to calcification.
© 2018 American Society for Bone and Mineral Research. © 2018 American Society for Bone and Mineral Research.

Entities:  

Keywords:  CALCIUM; CARDIOVASCULAR DISEASE; CKD; MINERAL METABOLISM; PHOSPHATE; VASCULAR CALCIFICATION

Mesh:

Substances:

Year:  2018        PMID: 30216554     DOI: 10.1002/jbmr.3572

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

1.  Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Colby J Vorland; Annabel Biruete; Pamela J Lachcik; Shruthi Srinivasan; Neal X Chen; Sharon M Moe; Kathleen M Hill Gallant
Journal:  J Bone Miner Res       Date:  2019-11-15       Impact factor: 6.741

2.  Effect of nutritional calcium and phosphate loading on calciprotein particle kinetics in adults with normal and impaired kidney function.

Authors:  Mark K Tiong; Michael M X Cai; Nigel D Toussaint; Sven-Jean Tan; Andreas Pasch; Edward R Smith
Journal:  Sci Rep       Date:  2022-05-05       Impact factor: 4.996

3.  Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling.

Authors:  Brian Czaya; Kylie Heitman; Isaac Campos; Christopher Yanucil; Dominik Kentrup; David Westbrook; Orlando Gutierrez; Jodie L Babitt; Grace Jung; Isidro B Salusky; Mark Hanudel; Christian Faul
Journal:  Elife       Date:  2022-03-18       Impact factor: 8.713

4.  PTH suppression by calcitriol does not predict off-target actions in experimental CKD.

Authors:  Bruno A Svajger; Cynthia M Pruss; Kimberly J Laverty; Jason G E Zelt; Glenville Jones; Martin Kaufmann; Martin Petkovich; Rachel M Holden; Michael A Adams
Journal:  Pharmacol Res Perspect       Date:  2020-06

5.  Development of experimental chronic kidney disease and vascular calcification alters diurnal variation of phosphate and its hormonal regulators.

Authors:  Bruno A Svajger; Justin L H Riddoch; Cynthia M Pruss; Kimberly J Laverty; Emilie Ward; Rachel M Holden; Michael A Adams
Journal:  Physiol Rep       Date:  2020-11

Review 6.  New Insights to the Crosstalk between Vascular and Bone Tissue in Chronic Kidney Disease-Mineral and Bone Disorder.

Authors:  Maria L Mace; Søren Egstrand; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  Metabolites       Date:  2021-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.